These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24697357)

  • 1. Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients.
    Dhanarajan A; Hsu JW; le Coutre P; Wingard JR; Chang M; Norkin M
    Br J Haematol; 2014 Aug; 166(4):619-21. PubMed ID: 24697357
    [No Abstract]   [Full Text] [Related]  

  • 2. BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients.
    le Coutre P; Reinke P; Neuhaus R; Trappe R; Ringel F; Lalancette M; Hemmati PG; Dörken B; Daniel PT
    Eur J Haematol; 2010 Jan; 84(1):26-33. PubMed ID: 19799626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic myeloid leukemia after renal transplantation: report of a new case and review of the bibliography].
    Sanz L; Cervantes F; Esteve J; Vilardell J; Marín P; Rozman C; Montserrat E
    Sangre (Barc); 1996 Oct; 41(5):391-3. PubMed ID: 9026925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic myeloid leukemia after kidney transplantation].
    Fernández-Avilés F; Ribera JM; Batlle M; Lauzurica R
    Sangre (Barc); 1997 Feb; 42(1):85-6. PubMed ID: 9229811
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic myeloid leukemia following heart transplantation and immunosuppression with tacrolimus.
    Sbenghe MM; Florea AD; Mather P; Gitelson E
    Clin Adv Hematol Oncol; 2011 Aug; 9(8):623-7. PubMed ID: 22236991
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic myeloid leukemia following kidney transplantation.
    Pelloso LA; Campos MG; Nascimento M; Silva MR; Pestana JO; Chauffaille Mde L
    Leuk Res; 2005 Mar; 29(3):353-5. PubMed ID: 15661273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
    Gardiner N; Lawler M; O'Riordan J; De'Arce M; McCann SR
    Leukemia; 1997 Apr; 11 Suppl 3():512-5. PubMed ID: 9209441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
    Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Asnafi V; Rubio MT; Delabesse E; Villar E; Davi F; Damaj G; Hirsch I; Dhédin N; Vernant JP; Varet B; Buzyn A; Macintyre E
    Leukemia; 2006 May; 20(5):793-9. PubMed ID: 16541140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.
    Löfström B; Backlin C; Sundström C; Hellström-Lindberg E; Ekbom A; Lundberg IE
    Rheumatology (Oxford); 2009 Oct; 48(10):1222-6. PubMed ID: 19608725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia.
    Holowiecki J; Giebel S; Wojnar J; Krawczyk-Kulis M; Markiewicz M; Holowiecka-Goral A; Freund M; Casper J
    Br J Haematol; 2008 Jun; 142(2):284-92. PubMed ID: 18492101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular remission of chronic myeloid leukaemia in a patient with hepatitis and a second kidney transplant].
    Castillo-Rama M; Grande C; Martínez-Sanchez P; Olavarria E; Marín D; Paz-Artal E; Andrés A; Morales JM
    Nefrologia; 2009; 29(6):604-7. PubMed ID: 19936007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized intervention guided by BCR-ABL transcript levels after HLA-identical sibling donor transplantation improves HSCT outcomes for patients with chronic myeloid leukemia.
    Huang XJ; Xu LP; Liu KY; Liu DH; Chen H; Liu YR; Chen YH; Han W; Wang Y
    Biol Blood Marrow Transplant; 2011 May; 17(5):649-56. PubMed ID: 20691800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplantation chronic myeloid leukemia.
    le Coutre P; Schwarz M; Daniel P; Dörken B
    Clin Adv Hematol Oncol; 2011 Aug; 9(8):627-9. PubMed ID: 22236992
    [No Abstract]   [Full Text] [Related]  

  • 15. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
    Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER
    J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse.
    Ringhoffer M; Harsdorf Sv; Schmitt M; Wiesneth M; Zenz T; Stilgenbauer S; Greiner J; Döhner K; Marx M; Döhner H; Bunjes D
    Br J Haematol; 2007 Jan; 136(1):127-30. PubMed ID: 17222200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
    Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S
    Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
    Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
    Lichtman MA
    Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.